GAN & LEE PHARMACEUTICALS

Founded in 1998, Gan & Lee Pharmaceuticals (hereinafter referred to as Gan & Lee, stock code: 603087.SH) is a leading pharmaceutical company in China, specializing in the development, production, and commercialization of insulin analogs and medical devices. Headquartered in Beijing, Gan & Lee has an industrial park of about 200,000 square meters. The company has more than 5,500 employees globally... Gan & Lee develops medical devices to support the treatment of diabetes. GanleeFine®, an injection pen needle for insulin received clearance from the U.S. Food and Drug Administration (FDA).

Also known as: Gan & Lee, Gan & Lee Biotechnology (Shanghai) Co.,Ltd., Gan & Lee Company, Gan & Lee Pharmaceuticals Co., Ltd., Gan & Lee Pharmaceuticals Jiangsu Co., Ltd., Gan & Lee Pharmaceuticals Shandong Co., Ltd., Gan&Lee Holdings Limited, Gan&Lee Pharmaceuticals Europe GmbH

Primary location: Bridgewater United States